|
US3989816A
(en)
|
1975-06-19 |
1976-11-02 |
Nelson Research & Development Company |
Vehicle composition containing 1-substituted azacycloheptan-2-ones
|
|
JPS567710A
(en)
|
1979-06-28 |
1981-01-27 |
Sansho Seiyaku Kk |
Whitening cosmetic
|
|
US4444762A
(en)
|
1980-04-04 |
1984-04-24 |
Nelson Research & Development Company |
Vehicle composition containing 1-substituted azacyclopentan-2-ones
|
|
DE3583799D1
(de)
|
1985-01-11 |
1991-09-19 |
Abbott Lab Ltd |
Feste zubereitung mit langsamer freisetzung.
|
|
JP2773959B2
(ja)
|
1990-07-10 |
1998-07-09 |
信越化学工業株式会社 |
大腸内放出性固形製剤
|
|
US6605712B1
(en)
|
1990-12-20 |
2003-08-12 |
Arch Development Corporation |
Gene transcription and ionizing radiation: methods and compositions
|
|
GB9603095D0
(en)
|
1996-02-14 |
1996-04-10 |
Zeneca Ltd |
Quinazoline derivatives
|
|
ID19609A
(id)
|
1996-07-13 |
1998-07-23 |
Glaxo Group Ltd |
Senyawa-senyawa heterosiklik
|
|
US6225318B1
(en)
|
1996-10-17 |
2001-05-01 |
Pfizer Inc |
4-aminoquinazolone derivatives
|
|
US6002008A
(en)
|
1997-04-03 |
1999-12-14 |
American Cyanamid Company |
Substituted 3-cyano quinolines
|
|
TW436485B
(en)
|
1997-08-01 |
2001-05-28 |
American Cyanamid Co |
Substituted quinazoline derivatives
|
|
RS49779B
(sr)
|
1998-01-12 |
2008-06-05 |
Glaxo Group Limited, |
Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
|
|
UA73092C2
(uk)
|
1998-07-17 |
2005-06-15 |
Брістол-Майерс Сквібб Компані |
Таблетка з ентеросолюбільним покриттям і спосіб її приготування
|
|
DE69924735T2
(de)
|
1998-07-28 |
2006-01-19 |
Tanabe Seiyaku Co., Ltd. |
Zur wirkstoffabgabe an zielorten im darm fähige zubereitung
|
|
JP3270834B2
(ja)
|
1999-01-27 |
2002-04-02 |
ファイザー・プロダクツ・インク |
抗がん剤として有用なヘテロ芳香族二環式誘導体
|
|
AR035851A1
(es)
|
2000-03-28 |
2004-07-21 |
Wyeth Corp |
3-cianoquinolinas, 3-ciano-1,6-naftiridinas y 3-ciano-1,7-naftiridinas como inhibidoras de proteina quinasas
|
|
US6521618B2
(en)
|
2000-03-28 |
2003-02-18 |
Wyeth |
3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
|
|
ES2201899B1
(es)
|
2002-04-01 |
2005-06-01 |
Almirall Prodesfarma, S.A. |
Derivados de la azaindolilpiperidina como agentes antihistaminicos y antialergicos.
|
|
KR100735639B1
(ko)
|
2004-12-29 |
2007-07-04 |
한미약품 주식회사 |
암세포 성장 억제 효과를 갖는 퀴나졸린 유도체 및 이의제조방법
|
|
PE20070207A1
(es)
|
2005-07-22 |
2007-03-09 |
Genentech Inc |
Tratamiento combinado de los tumores que expresan el her
|
|
ES2364901T3
(es)
|
2005-11-15 |
2011-09-16 |
Array Biopharma, Inc. |
Procesos e intermedios para la preparación de derivados de n4-fenil-quinazolin-4-amina.
|
|
CN101003514A
(zh)
|
2006-01-20 |
2007-07-25 |
上海艾力斯医药科技有限公司 |
喹唑啉衍生物、其制备方法及用途
|
|
DE102006012251A1
(de)
*
|
2006-03-15 |
2007-11-08 |
Grünenthal GmbH |
Substituierte 4-Amino-chinazolin-Derivate und ihre Verwendung zur Herstellung von Arzneimitteln
|
|
WO2007114926A2
(en)
|
2006-04-04 |
2007-10-11 |
The Regents Of The University Of California |
Kinase antagonists
|
|
EP2049502B1
(en)
|
2006-07-28 |
2012-01-04 |
Novartis AG |
2,4-substituted quinazolines as lipid kinase inhibitors
|
|
UY31137A1
(es)
|
2007-06-14 |
2009-01-05 |
Smithkline Beecham Corp |
Derivados de quinazolina como inhibidores de la pi3 quinasa
|
|
WO2009012647A1
(fr)
|
2007-07-20 |
2009-01-29 |
Shanghai Hengrui Pharmaceutical Co., Ltd. |
Procédés de préparation de dérivés de quinazoline et leurs utilisations pharmaceutiques
|
|
EP2060565A1
(en)
|
2007-11-16 |
2009-05-20 |
4Sc Ag |
Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
|
|
EP2303890A4
(en)
|
2008-06-19 |
2012-04-11 |
Progenics Pharm Inc |
INHIBITORS OF PHOSPHATIDYLINOSITE-3-KINASE
|
|
EP2323659A4
(en)
|
2008-08-05 |
2012-03-14 |
Abbott Lab |
COMPOUNDS USEFUL AS INHIBITORS OF PROTEIN KINASES
|
|
AR079814A1
(es)
|
2009-12-31 |
2012-02-22 |
Otsuka Pharma Co Ltd |
Compuestos heterociclicos, composiciones farmaceuticas que los contienen y sus usos
|
|
ES2565627T3
(es)
|
2010-07-30 |
2016-04-06 |
Oncotherapy Science, Inc. |
Derivados de quinolina e inhibidores de MELK que contienen los mismos
|
|
DE102010049595A1
(de)
|
2010-10-26 |
2012-04-26 |
Merck Patent Gmbh |
Chinazolinderivate
|
|
US8664230B2
(en)
|
2011-03-17 |
2014-03-04 |
The Asan Foundation |
Pyridopyrimidine derivatives and use thereof
|
|
ITMI20110480A1
(it)
|
2011-03-25 |
2012-09-26 |
F I S Fabbrica Italiana Sint P A |
Procedimento per la preparazione di lapatinib e suoi sali
|
|
KR20140048216A
(ko)
|
2011-06-29 |
2014-04-23 |
오츠카 세이야쿠 가부시키가이샤 |
치료 화합물로서의 퀴나졸린 및 관련된 사용 방법
|
|
US9499530B2
(en)
|
2011-08-01 |
2016-11-22 |
Hangzhou Minsheng Institutes For Pharma Research |
Quinazoline derivative, composition having the derivative, and use of the derivative in preparing medicament
|
|
US8785459B2
(en)
|
2011-12-27 |
2014-07-22 |
Development Center For Biotechnology |
Quinazoline compounds as kinase inhibitors
|
|
US20130331405A1
(en)
|
2012-06-12 |
2013-12-12 |
The Regents Of The University Of California |
PIK3CA Mutation Status and SASH1 Expression Predicts Synergy Between Lapatinib and an AKT Inhibitor in HER2 Positive Breast Cancer
|
|
CA2969974C
(en)
|
2014-12-15 |
2020-08-04 |
The Regents Of The University Of Michigan |
Small molecule inhibitors of egfr and pi3k
|
|
PE20181366A1
(es)
*
|
2015-08-03 |
2018-08-27 |
Bristol Myers Squibb Co |
Compuestos heterociclicos utiles como moduladores de factor de necrosis tumoral (tnf) alfa
|
|
CN110022878A
(zh)
*
|
2016-11-03 |
2019-07-16 |
密执安大学评议会 |
Egfr/pi3k的小分子双重抑制剂及其用途
|
|
US20190002460A1
(en)
|
2017-06-28 |
2019-01-03 |
The Regents Of The University Of Michigan |
Small molecule inhibitors of egfr and pi3k
|
|
EP3955923A1
(en)
*
|
2019-04-18 |
2022-02-23 |
The Regents Of The University Of Michigan |
Combination with checkpoint inhibitors to treat cancer
|
|
BR112021022099A2
(pt)
*
|
2019-05-31 |
2021-12-28 |
Chiesi Farm Spa |
Derivados de amino quinazolina como inibidores de p2x3
|